Diabeto-Cardiology

Name: Diabeto-Cardiology
Price: 160.99 USD
Availability: InStock
ISBN: 9780323878623

A Companion to Braunwald’s Heart Disease

by Darren K. McGuire, Nikolaus Marx

2nd Edition

Publisher: Saunders

(0 reviews)

Compare Prices

VitalSourceLifetime Access$160.99 AmazonKindle$160.99 AlibrisLifetime Access$160.99

Book Details

Print ISBN	9780323878623
eText ISBN	9780323878630
Publisher	Saunders
Publishing Year	2026
Edition	2nd Edition
Language	English
Pages	416

Diabeto-Cardiology: A Companion to Braunwald’s Heart Disease, 2nd Edition offers specialized guidance for managing clinical cases where cardiovascular disease and diabetes occur together. Authored by Darren K. McGuire and Nikolaus Marx, this textbook connects foundational metabolic mechanisms with active management strategies. It outlines how glucose dysregulation directly impacts vascular health and patient outcomes.

The text details how sodium-glucose cotransporter (SGLT) inhibitors and GLP-1 receptor agonists affect cardiovascular and renal outcomes. Coverage extends across therapeutic interventions for atherosclerotic vascular conditions, heart failure prevention, and renal disease progression. Additional chapters review surgical options, percutaneous coronary interventions, antithrombotic therapies, and structured lifestyle modifications.

To facilitate practical clinical application, this 416-page volume incorporates dedicated Clinical Practice Points and Take Home Summaries across its chapters. The text suits cardiologists, diabetologists, endocrinologists, and practicing clinicians, offering structured instructional support for subspecialty medical courses and postgraduate cardiology training programs.

Chapter 1: Definition and Epidemiology of Type 2 Diabetes Mellitus
Chapter 2: Insulin Resistance: Pathophysiology, Molecular Mechanisms, and Genetic Insights
Chapter 3: Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
Chapter 4: Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes
Chapter 5: Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease
Chapter 6: Epidemiology of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease
Chapter 7: Pathology and Vascular Biology of Atherosclerosis in Patients With Type 2 Diabetes
Chapter 8: Risk Stratification Among Patients With Type 2 Diabetes With or at Risk for Atherosclerotic Cardiovascular Disease
Chapter 9: Epidemiology and Pathophysiology of Heart Failure With Preserved and With Reduced Ejection Fraction in Patients With Type 2 Diabetes
Chapter 10: Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes
Chapter 11: Regulatory Approach to Medications for Type 2 Diabetes: Past, Present, and Future
Chapter 12: Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors
Chapter 13: Cardiovascular and Kidney Effects of Glucagon-Like Peptide 1 Receptor Agonists
Chapter 14: Antihyperglycemic Medications With Proven Cardiovascular Safety
Chapter 15: Prevention of Heart Failure in People With Diabetes
Chapter 16: Treatment of Patients With Reduced and With Preserved Ejection Fraction Heart Failure in Patients With Type 2 Diabetes
Chapter 17: Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients With Type 2 Diabetes
Chapter 18: Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes
Chapter 19: Effect of Lipid Management on Coronary Heart Disease Risk in Persons With Type 2 Diabetes
Chapter 20: Effect of Antithrombotic Therapy on Coronary Heart Disease Risk in People With Diabetes Mellitus
Chapter 21: Role of Percutaneous Coronary Intervention in Patients With Diabetes
Chapter 22: Peripheral Artery Disease in Persons With Type 2 Diabetes
Chapter 23: Cerebrovascular Disease in Persons With Diabetes
Chapter 24: Atrial Fibrillation in Persons With Type 2 Diabetes
Chapter 25: Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients With Type 2 Diabetes
Chapter 26: Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Females, Racial/Ethnic Minorities, and the Elderly
Chapter 27: The Quality Chasm and the Need for Implementation Science to Reduce Cardiovascular Disease Risk in Type 2 Diabetes